Blood Testing Study for GBS Vaccine Safety
Part of Infections clinical trials.
This study tests blood samples from women who received a Group B Streptococcus (GBS) vaccine during pregnancy to ensure the vaccine is working safely and correctly. Researchers want to check your immune response and confirm the vaccine quality.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an HIV-negative woman who received the GBS6 vaccine while pregnant and completed the full study period
- You can be reached by phone and are willing to give informed consent
- You are able and willing to provide a blood sample
- You have not received a blood or plasma transfusion in the last 3 months
- You are not currently on immunosuppressive medications (drugs that weaken the immune system) or systemic corticosteroids
- You do not have untreated syphilis or HIV, current substance abuse, or serious health conditions like heart disease or severe anemia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a vaccine against Group B Streptococcus (GBS) during pregnancy to see if it can protect newborns from infection. Healthy pregnant women with a single baby can join.
This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.
This study is a registry that collects information about the health and outcomes of babies and children who had a serious Group B Strep infection around birth. It aims to better understand the long-term effects and improve care for families impacted by this infection.
This early-phase study looks at whether swabbing a mother’s vagina during a planned C-section (“vaginal seeding”) can help shape a newborn’s early respiratory and gut microbes. The goal is to see if this approach is safe and may influence early-life breathing health.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
This study collects blood samples to help researchers develop better tests. It is for healthy people who have not had a pneumococcal vaccine before.
Hear when a new Group B Strep Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.